MAI Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.2K | Buy |
3,293
+697
| +27% | +$11.7K | ﹤0.01% | 1700 |
|
|
2025
Q1 | $39.9K | Sell |
2,596
-50
| -2% | -$769 | ﹤0.01% | 1750 |
|
|
2024
Q4 | $58.3K | Buy |
+2,646
| New | +$58.3K | ﹤0.01% | 1594 |
|
|
2018
Q3 | – | Sell |
-8,392
| Closed | -$204K | – | 485 |
|
|
2018
Q2 | $204K | Buy |
+8,392
| New | +$204K | 0.01% | 439 |
|
|
2017
Q3 | – | Sell |
-17,904
| Closed | -$595K | – | 452 |
|
|
2017
Q2 | $595K | Sell |
17,904
-6,024
| -25% | -$200K | 0.04% | 257 |
|
|
2017
Q1 | $768K | Sell |
23,928
-551
| -2% | -$17.7K | 0.05% | 220 |
|
|
2016
Q4 | $887K | Buy |
24,479
+5,104
| +26% | +$185K | 0.06% | 194 |
|
|
2016
Q3 | $891K | Buy |
19,375
+853
| +5% | +$39.2K | 0.07% | 193 |
|
|
2016
Q2 | $930K | Sell |
18,522
-373
| -2% | -$18.7K | 0.07% | 184 |
|
|
2016
Q1 | $1.01M | Sell |
18,895
-414
| -2% | -$22.2K | 0.08% | 176 |
|
|
2015
Q4 | $1.27M | Buy |
19,309
+114
| +0.6% | +$7.48K | 0.1% | 156 |
|
|
2015
Q3 | $1.08M | Sell |
19,195
-450
| -2% | -$25.4K | 0.08% | 183 |
|
|
2015
Q2 | $1.16M | Buy |
19,645
+404
| +2% | +$23.9K | 0.08% | 191 |
|
|
2015
Q1 | $1.2M | Buy |
19,241
+1,404
| +8% | +$87.5K | 0.08% | 184 |
|
|
2014
Q4 | $1.03M | Sell |
17,837
-973
| -5% | -$56K | 0.07% | 188 |
|
|
2014
Q3 | $1.01M | Buy |
18,810
+33
| +0.2% | +$1.77K | 0.1% | 153 |
|
|
2014
Q2 | $984K | Sell |
18,777
-214
| -1% | -$11.2K | 0.09% | 145 |
|
|
2014
Q1 | $1M | Sell |
18,991
-1,520
| -7% | -$80.3K | 0.1% | 143 |
|
|
2013
Q4 | $822K | Sell |
20,511
-8,599
| -30% | -$345K | 0.09% | 156 |
|
|
2013
Q3 | $1.1M | Sell |
29,110
-4,508
| -13% | -$170K | 0.14% | 121 |
|
|
2013
Q2 | $1.32M | Buy |
+33,618
| New | +$1.32M | 0.17% | 103 |
|